Cargando…

Differentiating Polycystic Ovary Syndrome from Adrenal Disorders

Although polycystic ovary syndrome (PCOS) is primarily considered a hyperandrogenic disorder in women characterized by hirsutism, menstrual irregularity, and polycystic ovarian morphology, an endocrinological investigation should be performed to rule out other hyperandrogenic disorders (e.g., virili...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yesiladali, Mert, Yazici, Melis G. K., Attar, Erkut, Kelestimur, Fahrettin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498167/ https://www.ncbi.nlm.nih.gov/pubmed/36140452 http://dx.doi.org/10.3390/diagnostics12092045

Ejemplares similares

POTENTIAL INFLUENCE OF CORONAVIRUS DISEASE 2019 (COVID-19) ON THE OUTCOMES OF IN-VITRO FERTILIZATION
por: Yesiladali, Mert, et al.
Publicado: (2022)

SPERM CONCENTRATION, SPERM MOTILITY AND TOTAL MOTILE SPERM COUNT ARE NOT AFFECTED BY CORONOVIRUS DISEASE 2019 (COVID-19) INFECTION
por: Kocer Yazici, Melis Gokce, et al.
Publicado: (2022)

Neuroendocrine Disturbances after Brain Damage: An Important and Often Undiagnosed Disorder
por: Tanriverdi, Fatih, et al.
Publicado: (2015)

Endometriosis and polycystic ovary syndrome are diametric disorders
por: Dinsdale, Natalie L., et al.
Publicado: (2021)

Hypothalamic-Pituitary Axis Function and Adrenal Insufficiency in COVID-19 Patients
por: Durcan, Emre, et al.
Publicado: (2023)

Polycystic Ovary Syndrome May Be an Autoimmune Disorder
por: Mobeen, Hifsa, et al.
Publicado: (2016)

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

Polycystic Ovary Syndrome Among Female Adolescents With Congenital Adrenal Hyperplasia
por: Abdelhamed, Marwa H, et al.
Publicado: (2021)

Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
por: Moran, Carlos, et al.
Publicado: (2012)

Polycystic Ovary Syndrome and Psychotic Disorder
por: Doretto, Larissa, et al.
Publicado: (2020)

Thyroid disorders and polycystic ovary syndrome: An emerging relationship
por: Singla, Rajiv, et al.
Publicado: (2015)

Polycystic Ovary Syndrome in Adolescence
por: Deans, Rebecca
Publicado: (2019)

Evolutionary origins of polycystic ovary syndrome: An environmental mismatch disorder
por: Charifson, Mia A, et al.
Publicado: (2019)

Pituitary dysfunction following traumatic brain injury: clinical perspectives
por: Tanriverdi, Fatih, et al.
Publicado: (2015)

Adrenal Androgen Predictive Effects on Clinical and Metabolic Abnormalities of Polycystic Ovary Syndrome
por: Medeiros, Sebastião Freitas de, et al.
Publicado: (2022)

Features of Polycystic Ovary Syndrome in adolescence
por: Tsikouras, P, et al.
Publicado: (2015)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

Update on polycystic ovary syndrome
por: Kim, Jin Ju
Publicado: (2021)

Role of insulin and insulin resistance in androgen excess disorders
por: Unluhizarci, Kursad, et al.
Publicado: (2021)

Phenotype and Metabolic Disorders in Polycystic Ovary Syndrome
por: Głuszak, Olgierd, et al.
Publicado: (2012)

Sexual function in women with androgen excess disorders: classic forms of congenital adrenal hyperplasia and polycystic ovary syndrome
por: Kępczyńska-Nyk, A., et al.
Publicado: (2020)

Treatment options for polycystic ovary syndrome
por: Badawy, Ahmed, et al.
Publicado: (2011)

Dyslipidemia in women with polycystic ovary syndrome
por: Kim, Jin Ju, et al.
Publicado: (2013)

Cardiometabolic risk in polycystic ovary syndrome
por: Bajuk Studen, Katica, et al.
Publicado: (2018)

Polycystic ovary syndrome and mitochondrial dysfunction
por: Zhang, Jingshun, et al.
Publicado: (2019)

Polycystic Ovary Syndrome and Gender Identity
por: Liu, Minghao, et al.
Publicado: (2020)

Estrogen Receptors in Polycystic Ovary Syndrome
por: Xu, Xue-Ling, et al.
Publicado: (2021)

Neuroendocrine Determinants of Polycystic Ovary Syndrome
por: Szeliga, Anna, et al.
Publicado: (2022)

Dietary supplements for polycystic ovary syndrome
por: KIANI, AYSHA KARIM, et al.
Publicado: (2022)

Comparison of a combination test (1 μg ACTH test plus glucagon test) versus 1 μg ACTH test and glucagon test in the evaluation of the hypothalamic-pituitary-adrenal axis in patients with pituitary disorders
por: Unluhizarci, Kursad, et al.
Publicado: (2020)

Optimal management of subfertility in polycystic ovary syndrome
por: Berger, Joshua J, et al.
Publicado: (2014)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Intersection of Polycystic Ovary Syndrome and the Gut Microbiome
por: Rizk, Maryan G, et al.
Publicado: (2020)

Complementary Therapy in Polycystic Ovary Syndrome
por: Aquino, C. I., et al.
Publicado: (2014)

Immunophenotypic Profiles in Polycystic Ovary Syndrome
por: Hu, Cong, et al.
Publicado: (2020)

An Update on Contraception in Polycystic Ovary Syndrome
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

Association Between Vitamin D and Adrenal Parameters with Metabolic and Inflammatory Markers in Polycystic Ovary Syndrome
por: Maidana, P., et al.
Publicado: (2019)

Role of Statin Drugs for Polycystic Ovary Syndrome
por: Cassidy-Vu, Lisa, et al.
Publicado: (2016)

Common endocrine disorders associated with the polycystic ovary syndrome
por: Abdelazim, Ibrahim A., et al.
Publicado: (2021)

The management of infertility associated with polycystic ovary syndrome
por: Homburg, Roy
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_cni65drv39khodcm6fbvp56amj